Regulus Therapeutics' Corporate Minority Round

Regulus Therapeutics raised a round of funding on June 22, 2010. Investors include Sanofi.

Regulus Therapeutics (NASDAQ: RGLS), a biopharmaceutical company, focuses on the discovery and development of drugs that target RNAs to treat a range of diseases in the United States. The Company uses…

Articles about Regulus Therapeutics' Corporate Minority Round: